Evan Loh - Net Worth and Insider Trading
Evan Loh Net Worth
The estimated net worth of Evan Loh is at least $3 Million dollars as of 2024-12-27. Evan Loh is the CEO of Paratek Pharmaceuticals Inc and owns about 1,327,981 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $3 Million. Evan Loh is also the Director of Eiger BioPharmaceuticals Inc and owns about 267 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $2,270. Details can be seen in Evan Loh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Evan Loh has not made any transactions after 2023-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Evan Loh
Evan Loh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Evan Loh owns 4 companies in total, including Paratek Pharmaceuticals Inc (PRTK) , Eiger BioPharmaceuticals Inc (EIGRQ) , and Alpine Immune Sciences Inc (ALPN) among others .
Click here to see the complete history of Evan Loh’s form 4 insider trades.
Insider Ownership Summary of Evan Loh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2023-09-21 | director & CEO |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-03-11 | director |
| ALPN | Alpine Immune Sciences Inc | 2015-06-16 | director |
 | | 2021-02-03 | director |
Evan Loh Latest Holdings Summary
Evan Loh currently owns a total of 2 stocks. Among these stocks, Evan Loh owns 1,327,981 shares of Paratek Pharmaceuticals Inc (PRTK) as of August 9, 2023, with a value of $3 Million and a weighting of 99.92%. Evan Loh also owns 267 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of March 15, 2021, with a value of $2,270 and a weighting of 0.08%.
Latest Holdings of Evan Loh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2023-08-09 | 1,327,981 | 2.23 | 2,961,398 |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2021-03-15 | 267 | 8.50 | 2,270 |
Holding Weightings of Evan Loh
Evan Loh Form 4 Trading Tracker
According to the SEC Form 4 filings, Evan Loh has made a total of 11 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 48,967 shares on August 9, 2023, which brought Evan Loh around $107,727.
According to the SEC Form 4 filings, Evan Loh has made a total of 1 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Eiger BioPharmaceuticals Inc is the sale of 67 shares on March 15, 2021, which brought Evan Loh around $20,280.
Insider Trading History of Evan Loh
- 1
Evan Loh Trading Performance
GuruFocus tracks the stock performance after each of Evan Loh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Evan Loh is -9.91%. GuruFocus also compares Evan Loh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Evan Loh within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Evan Loh's insider trading performs compared to the benchmark.
Performance of Evan Loh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.65 | | | | | |
| Relative Return to S&P 500(%) | 3.37 | | | | | |
Evan Loh Ownership Network
Evan Loh Owned Company Details
What does Paratek Pharmaceuticals Inc do?
Who are the key executives at Paratek Pharmaceuticals Inc?
Evan Loh is the director & CEO of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .
Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary
Over the past 18 months, Evan Loh made 1 insider transaction in Paratek Pharmaceuticals Inc (PRTK) with a net sale of 48,967. Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 34,526 shares made by William M. Haskel , a net sale of 31,250 shares made by Michael Bigham , and a net sale of 27,603 shares made by Randall B. Brenner .
In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.
Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Paratek Pharmaceuticals Inc Insider Transactions
Evan Loh Mailing Address
Above is the net worth, insider trading, and ownership report for Evan Loh. You might contact Evan Loh via mailing address: 75 Kneeland Street, Boston Ma 02111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
